Blood Pressure Medications: First-Line Treatment and Common Side Effects
For adults with hypertension requiring pharmacological treatment, start with thiazide/thiazide-like diuretics, ACE inhibitors (in non-Black patients), ARBs, or long-acting calcium channel blockers as first-line monotherapy, or use combination therapy with two of these agents if BP is ≥20/10 mmHg above target. 1
First-Line Antihypertensive Drug Classes
The most recent WHO 2022 guidelines 1 and multiple international guidelines 2, 3, 4 establish four primary drug classes as first-line therapy:
Thiazide and Thiazide-Like Diuretics
- Strongest evidence for mortality reduction (11.0% control vs 9.8% treatment; RR 0.89) 5
- Reduce stroke by 32% and total cardiovascular events by 30% 5
- Preferred for isolated systolic hypertension 2, 3
- Thiazide-like agents (chlorthalidone, indapamide) may offer superior cardiovascular protection compared to hydrochlorothiazide 6
ACE Inhibitors
- Reduce mortality by 17%, stroke by 35%, and coronary heart disease by 19% 5
- Not recommended as first-line in Black patients (Grade A) 2, 3
- Preferred in patients with diabetes, heart failure, or post-MI 7
Angiotensin Receptor Blockers (ARBs)
- Similar organ-protective effects to ACE inhibitors 7
- Better tolerated than ACE inhibitors (no cough) 8
- Combination of ACE inhibitor + ARB is NOT recommended (Grade A) 2, 3
Long-Acting Calcium Channel Blockers
- Reduce stroke by 42% and total cardiovascular events by 29% 5
- Particularly effective in isolated systolic hypertension 2, 3
- Dihydropyridines (amlodipine, nifedipine) preferred over non-dihydropyridines
Beta-Blockers: Limited First-Line Role
Beta-blockers are NOT recommended as first-line therapy for uncomplicated hypertension in patients ≥60 years old (Grade A) 2, 3. They should be reserved for:
- Patients <60 years with uncomplicated hypertension 2, 3
- Compelling indications: post-MI, angina, heart failure, atrial fibrillation 4, 9
Combination Therapy Strategy
Most patients require ≥2 drugs to achieve target BP 10, 11. The WHO recommends combination therapy, preferably as single-pill combinations, for initial treatment 1:
Preferred Combinations (Grade B-C):
- ACE inhibitor or ARB + calcium channel blocker
- ACE inhibitor or ARB + thiazide/thiazide-like diuretic
- Calcium channel blocker + thiazide/thiazide-like diuretic
Combinations to Avoid:
- Non-dihydropyridine CCB + beta-blocker (caution, Grade D) 2, 3
- ACE inhibitor + ARB (not recommended, Grade A) 2, 3
Start with combination therapy immediately if SBP is ≥20 mmHg or DBP is ≥10 mmHg above target, but exercise caution in elderly or frail patients 2, 3.
Common Adverse Effects by Drug Class
Thiazide/Thiazide-Like Diuretics
- Hypokalemia (must be avoided, Grade C) 2, 3
- Hyperuricemia and gout
- Glucose intolerance and new-onset diabetes
- Hyponatremia
- Withdrawal rate: 11.3% vs 5.0% placebo (RR 2.38) 5
ACE Inhibitors
- Dry cough (most common, 5-20% of patients) 8
- Angioedema (rare but serious)
- Hyperkalemia (monitor in renal impairment)
- Acute kidney injury (particularly with bilateral renal artery stenosis)
- Contraindicated in pregnancy
ARBs
- Better tolerated than ACE inhibitors (no cough) 8
- Hyperkalemia
- Dizziness
- Acute kidney injury (same precautions as ACE inhibitors)
- Contraindicated in pregnancy
Calcium Channel Blockers
- Peripheral edema (especially with dihydropyridines)
- Headache
- Flushing
- Constipation (particularly with non-dihydropyridines like verapamil)
- Gingival hyperplasia
Beta-Blockers
- Highest withdrawal rate: 14.4% vs 3.1% placebo (RR 4.59) 5
- Fatigue and exercise intolerance
- Bradycardia
- Bronchospasm (avoid in asthma/COPD)
- Sexual dysfunction
- Masking of hypoglycemia symptoms
- Metabolic effects (glucose intolerance, dyslipidemia)
Resistant Hypertension Management
If BP remains uncontrolled on 2-3 first-line agents 2, 3:
- Add spironolactone 25-50 mg/day (reduces SBP by 6.6-8.7 mmHg, superior to doxazosin or bisoprolol) 6
- If spironolactone not tolerated (hyperkalemia in 4-40%, antiandrogenic effects):
- Screen for secondary hypertension causes 6
- Assess medication adherence and lifestyle factors 2, 3
Critical Pitfalls to Avoid
- Do not use high-dose thiazides: High-dose thiazides do not reduce mortality (RR 0.90) and have worse side effects than low-dose 5
- Avoid hypokalemia with diuretic monotherapy: Monitor potassium and supplement or use potassium-sparing agents 2, 3
- Monitor renal function and potassium when using ACE inhibitors/ARBs, especially with eGFR <45 mL/min/1.73 m² 6
- Do not delay treatment for extensive testing: Start treatment promptly; testing should not impede initiation 1
- Caution in elderly/frail patients: Start lower doses and titrate carefully to avoid hypotension 2, 3
Target Blood Pressure
Target BP <140/90 mmHg for all patients with hypertension 1. Target SBP <130 mmHg for high-risk patients (existing CVD, diabetes, CKD) 1, 4. Achieve target within 3 months with monthly follow-up 1.